Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor
Pj. Nathan et al., Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor, BEHAV PHARM, 11(7-8), 2000, pp. 639-642
Comparisons of the behavioural side-effect profiles of antidepressants that
inhibit either serotonin or both serotonin and noradrenaline reuptake, may
reveal differences in cognitive and psychomotor functions, which may be at
tributed to their relative pharmacological selectivity for potentiating mon
oamine neurotransmission in the central nervous system. The aim of the pres
ent study was to determine the acute pharmacodynamic effects of citalopram
and venlafaxine, on cognitive and psychomotor performance. Nine healthy mal
e volunteers received a single clinical dose of citalopram, venlafaxine or
amitriptyline (positive control) in a double-blind placebo-controlled desig
n. Cognitive and psychomotor tests and a subjective measure of sedation wer
e examined before and 1, 2 and 4 hours after drug administration. Citalopra
m improved psychomotor responses to sensory stimuli and sustained attention
, with significant: decreases in movement times of the choice reaction time
test and an increase in critical flicker fusion threshold. Venlafaxine did
not affect performances on any of the cognitive or psychomotor tests exami
ned. Differences may be related to relative potencies of the compounds for
monoamine reuptake inhibition. (C) 2000 Lippincott Williams & Wilkins.